EUVIMEDEUVIMED entdecken
Open Access

Concerted Actions of FoxO1 and PPARα in Hepatic Gene Expression and Metabolic Adaptation

Takumi Kitamoto iD, Hitoshi Watanabe, Yasutaka Miyachi, Makoto Miyabayashi, Li Qiang iD, Masahiko Ajiro, Akihide Yoshimi, Yoshiro Maezawa, Koutaro Yokote, Domenico Accili

Diabetes · 2025

DOI: 10.2337/db24-1173 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, 2025. Verfasst von Takumi Kitamoto und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diabetes, Metabolism and Endocrinology, Chiba University Hospital, Chiba, Japan. Hauptthemen laut MEDLINE: Adaptation, Physiological, Liver, Fasting, Forkhead Box Protein O1. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH/NCI Cancer Center, NCI NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Several transcription factors regulate the fasting response in liver. They include FoxO1 and FoxO3, CREB, C/EBP α/β, glucocorticoid receptor (GR), peroxisome proliferator–activated receptor-α (PPARα), FoxA2, hepatocyte nuclear factor-α (HNF4α), and others. Genome-wide chromatin occupancy studies revealed an unexpected overlap of FoxO1 and PPARα DNA binding sites at active intergenic and intron enhancers, yet their functional significance remains unknown. To address this gap in knowledge, we conducted molecular interaction analyses of these transcription factors and generated combined hepatocyte-specific ablation of the respective genes. Integrated analysis of hepatic RNA sequencing from these mice by FoxO1 and PPARα chromatin immunoprecipitation sequencing revealed a concerted regulation of glucose metabolism, with additive effects on in vivo glucose tolerance. Synergistic effects on glycogenesis were observed when PPARα was ablated in the absence of FoxO1, particularly following a high-fat diet. Free fatty acids increased following FoxO1 and were normalized by PPARα ablation, while liver triglyceride content increased in PPARα knockouts and was normalized by FoxO1 ablation. The findings highlight a functional relay between FoxO1 and PPRAα, linking insulin signaling with hepatic lipid metabolism, and offer insight into potential therapeutic strategies for metabolic diseases. Article Highlights FoxO1 and PPARα share significant DNA binding sites, regulating a coordinated transcriptional network in hepatic metabolism. FoxO1 and PPARα orchestrate distinct yet overlapping roles in gluconeogenesis and fatty acid/lipid metabolism. High-fat diet amplifies the metabolic interplay between FoxO1 and PPARα, with implications for insulin resistance management. Targeting the FoxO1-PPARα interplay offers novel strategies for treating selective insulin resistance and metabolic disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adaptation, PhysiologicalLiverFastingForkhead Box Protein O1PPAR alphaGene Expression RegulationGene Knockout TechniquesHepatocytesLipid MetabolismChromatin Immunoprecipitation SequencingTriglyceridesLiver GlycogenGlucoseDiet, High-FatInsulinAnimalsMiceModels, AnimalGene Expression ProfilingPrimary Cell CultureMice, Inbred C57BLMale

Substanzen

Foxo1 protein, mouseForkhead Box Protein O1Ppara protein, mousePPAR alphaTriglyceridesLiver GlycogenGlucoseInsulin

Autor:innen und Institutionen

  • Department of Diabetes, Metabolism and Endocrinology, Chiba University Hospital, Chiba, Japan.
  • Department of Endocrinology, Hematology and Gerontology, Chiba University Graduate School of Medicine, Chiba, Japan.
  • Department of Medicine and Naomi Berrie Diabetes Center, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY.
  • Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Department of Pharmacology, School of Basic Medical Sciences, State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing, China.
  • Division of Cancer RNA Research, National Cancer Center Research Institute, Tokyo, Japan.

ORCID-Profile: Takumi Kitamoto, Li Qiang

Förderung

  • NIH/NCI Cancer Center
  • NCI NIH HHS
  • NIDDK NIH HHS
  • JSPS
  • NIH HHS
  • NIH

Zitieren

APA

Kitamoto, T., Watanabe, H., Miyachi, Y., Miyabayashi, M., Qiang, L., Ajiro, M., Yoshimi, A., Maezawa, Y., Yokote, K., & Accili, D. (2025). Concerted Actions of FoxO1 and PPARα in Hepatic Gene Expression and Metabolic Adaptation. Diabetes. https://doi.org/10.2337/db24-1173

Vancouver

Kitamoto T, Watanabe H, Miyachi Y, Miyabayashi M, Qiang L, Ajiro M, et al. Concerted Actions of FoxO1 and PPARα in Hepatic Gene Expression and Metabolic Adaptation. Diabetes. 2025. doi:10.2337/db24-1173

BibTeX
@article{Kitamoto2025,
  author = {Kitamoto, Takumi and Watanabe, Hitoshi and Miyachi, Yasutaka and Miyabayashi, Makoto and Qiang, Li and Ajiro, Masahiko and Yoshimi, Akihide and Maezawa, Yoshiro and Yokote, Koutaro and Accili, Domenico},
  title = {Concerted Actions of FoxO1 and PPARα in Hepatic Gene Expression and Metabolic Adaptation},
  journal = {Diabetes},
  year = {2025},
  doi = {10.2337/db24-1173}
}
Kostenlos starten →